A 75-year-old man with Alzheimer’s disease is successfully managing his symptoms with microdoses of cannabis, according to a new case report published in the Journal of Medical Case Reports.
Under the supervision of an international team of investigators from The Federal University for Latin American Integration in Foz do Iguaçu, Brazil, and John Hopkins University in Baltimore, Maryland, the patient began to take small doses of a cannabis extract dietary supplement that had been imported by the patient’s family.
In the months following treatment, the patient’s scores on the Mini-Mental State Examination (MMSE) and Alzheimer’s Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) assessments improved. The patient also self-reported improvements in mood and overall quality of life.
Based on this case report, which demonstrates a potential use for cannabinoids as a therapeutic for Alzheimer’s disease, the researchers believe that further placebo-controlled clinical trials are needed on this topic to confirm and extend these observations.
Cannabis News
By Alexander Beadle
Published: Jul 20, 2022
